Maltin Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267K | Buy |
1,441
+5
| +0.3% | +$928 | 0.12% | 104 |
|
|
2025
Q1 | $301K | Sell |
1,436
-13
| -0.9% | -$2.72K | 0.14% | 102 |
|
|
2024
Q4 | $257K | Sell |
1,449
-74
| -5% | -$13.1K | 0.13% | 111 |
|
|
2024
Q3 | $301K | Buy |
1,523
+6
| +0.4% | +$1.19K | 0.15% | 97 |
|
|
2024
Q2 | $260K | Sell |
1,517
-80
| -5% | -$13.7K | 0.14% | 102 |
|
|
2024
Q1 | $291K | Buy |
1,597
+6
| +0.4% | +$1.09K | 0.16% | 95 |
|
|
2023
Q4 | $247K | Buy |
1,591
+8
| +0.5% | +$1.24K | 0.16% | 98 |
|
|
2023
Q3 | $236K | Sell |
1,583
-606
| -28% | -$90.3K | 0.16% | 101 |
|
|
2023
Q2 | $295K | Sell |
2,189
-835
| -28% | -$112K | 0.21% | 84 |
|
|
2023
Q1 | $482K | Buy |
3,024
+21
| +0.7% | +$3.35K | 0.35% | 67 |
|
|
2022
Q4 | $485K | Sell |
3,003
-322
| -10% | -$52K | 0.35% | 67 |
|
|
2022
Q3 | $446K | Buy |
3,325
+23
| +0.7% | +$3.09K | 0.35% | 77 |
|
|
2022
Q2 | $506K | Sell |
3,302
-42
| -1% | -$6.44K | 0.37% | 76 |
|
|
2022
Q1 | $542K | Sell |
3,344
-2,899
| -46% | -$470K | 0.36% | 75 |
|
|
2021
Q4 | $845K | Buy |
6,243
+52
| +0.8% | +$7.04K | 0.51% | 59 |
|
|
2021
Q3 | $668K | Buy |
+6,191
| New | +$668K | 0.41% | 60 |
|
|
2020
Q3 | – | Sell |
-2,098
| Closed | -$206K | – | 87 |
|
|
2020
Q2 | $206K | Buy |
+2,098
| New | +$206K | 0.16% | 80 |
|